NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 128 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR Cómo los ensayos clínicos pueden llevar a un tratamiento que salve... October 12, 2023 Pembrolizumab Approved for Some Patients with Advanced Esophageal Cancer August 28, 2019 Physical Activity May Lessen the Effects of Chemobrain, Study Finds August 26, 2021 Neoadjuvant Chemoimmunotherapy Superior to Neoadjuvant Chemotherapy with Event-Free Survival Benefit in... April 10, 2024 Load more HOT NEWS Neoadjuvant Treatment with Dual Immune Checkpoint Inhibitors Plus Chemotherapy Produces Numerically... Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers Tailored Psychotherapy Eases Depression in People with Advanced Cancer Women in Science: Celebrating with our Women of Influence initiative
